Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

The New York Times – Business:

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Christina Jewett
Author: Christina Jewett

This post first appeared in The New York Times – Business. Read the original article.

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Food and Drug Administration, Pregnancy and Childbirth, Premature Babies, Regulation and Deregulation of Industry
←Broadway Theater To Be Renamed In Honor Of Lena Horne
Arnold Schwarzenegger And Sylvester Stallone Carve Pumpkins Together For Halloween→

More posts

  • Russell Brand’s wife says she’ll honour prison rules after message row

  • UN climate conference ends without deal as countries clash over fossil fuels, finance

  • Sheila Mangubat Dies: ’90 Day Fiancé: Before the 90 Days’ Star Was 35

  • Delta tech issue delays Atlanta-bound flights head of Thanksgiving

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube